WEDNESDAY, Jan. 5, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Wednesday endorsed the emergency use of Pfizer’s booster shots for children ages 12 to 17, expanding protection to adolescents and teens as students return to classes and the highly contagious Omicron variant surges acrossContinue Reading
WEDNESDAY, Jan. 5, 2021 (HealthDay News) – Be concerned about the rapidly spreading Omicron variant, President Joe Biden urged Americans on Tuesday, but don’t be alarmed. Biden delivered that message to reporters prior to a meeting with his COVID-19 response team, saying he was trying to convey both his administration’sContinue Reading
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — While the Omicron variant appears wily enough to evade people’s antibodies, researchers report that it should have a much harder time slipping past a person’s T-cells. “Despite being a preliminary study, we believe this is positive news. Even if Omicron, or some otherContinue Reading
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shotContinue Reading
MONDAY, Jan. 3, 2022 (HealthDay News) — Israel will now offer a fourth dose of COVID-19 vaccine to an expanded group of people, as it works to control a wave of the highly contagious Omicron variant. Israeli Prime Minister Naftali Bennett said Sunday that the country would provide vaccines toContinue Reading
MONDAY, Jan. 3, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s booster shot against COVID-19 for youths aged 12 to 15. The move comes as the Omicron variant spreads across the country and students return to classrooms following the holidayContinue Reading
MONDAY, Jan. 3, 2022 (HealthDay News) — An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for childrenContinue Reading
THURSDAY, Dec. 30, 2021 (HealthDay News) — New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention. The vaccine was first authorizedContinue Reading
THURSDAY, Dec. 30, 2021 (HealthDay News) — New data out of South Africa finds that a booster dose of Johnson & Johnson’s COVID-19 vaccine appears to provide strong protection against severe disease caused by the fast-spreading Omicron variant. The study, which was published online and has not yet undergone peerContinue Reading
WEDNESDAY, Dec. 29, 2021 (HealthDay News) — New antiviral pills for COVID-19 recently authorized for emergency use in high-risk people by the U.S. Food and Drug Administration should give doctors an easier means of keeping people out of the hospital. But the initial hype is giving way to reality, asContinue Reading